Biocept inc (BIOC)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Jun'13Mar'13
Net revenues

1,446

1,783

1,529

1,191

1,024

859

761

822

806

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenues

-

-

-

-

-

859

-

-

-

995

1,111

1,278

1,683

1,291

1,047

662

221

218

164

76

150

75

10

19

28

48

35

Costs and expenses:
Cost of revenues

2,946

2,872

2,832

2,673

2,599

2,435

2,481

2,699

2,434

2,359

2,487

2,368

2,129

1,899

1,876

1,669

1,474

1,275

1,159

1,013

1,147

614

538

359

658

593

547

Gross loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-340

-630

-544

-512

Research and development expenses

1,312

1,161

1,163

1,148

1,223

1,288

1,089

1,019

1,070

908

856

841

757

668

600

716

728

784

677

744

651

1,070

1,310

1,107

1,008

690

710

General and administrative expenses

1,904

1,911

1,700

1,676

1,681

1,632

1,793

1,708

1,938

1,650

1,834

1,798

1,906

1,636

1,918

1,517

1,487

1,404

1,630

1,359

1,292

1,231

1,060

1,032

1,876

478

451

Sales and marketing expenses

1,465

1,489

1,462

1,614

1,374

1,440

1,404

1,433

1,636

1,642

1,675

1,746

1,278

1,179

1,278

1,291

1,304

1,264

1,055

851

709

890

812

423

11

27

96

Total costs and expenses

7,629

7,434

7,158

7,112

6,879

6,797

6,769

6,861

7,080

6,561

6,854

6,755

6,071

5,384

5,673

5,195

4,994

4,728

4,523

3,967

3,800

-

3,721

-

-

-

-

Loss from operations

-6,182

-5,651

-5,629

-5,921

-5,854

-5,938

-6,007

-6,038

-6,273

-5,566

-5,742

-5,476

-4,388

-4,092

-4,626

-4,532

-4,773

-4,510

-4,358

-3,890

-3,650

-3,731

-3,711

-2,904

-3,527

-1,741

-1,769

Other expense:
Interest expense

56

62

62

63

61

80

63

84

82

97

88

214

82

132

154

99

138

145

175

169

149

149

151

94

1,394

510

467

Warrant inducement expense

2,102

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant inducement and other expenses

-

-

-

1,831

-

-

-

30

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-3

-2

206

-283

-317

Other income

-

-

-

-

-

-

-

-

-

-

-

-

38

38

38

38

38

-

38

25

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

-5

Total other expense

-2,158

-62

-62

-1,894

-61

-74

-39

-114

-82

-97

-75

-214

-44

-94

-116

-61

-100

-106

-137

-143

-149

-149

-148

-92

-1,600

-233

-155

Loss before income taxes

-8,341

-5,713

-5,691

-7,816

-5,916

-6,012

-6,047

-6,153

-6,356

-5,663

-5,818

-5,691

-4,432

-4,186

-4,743

-4,593

-4,873

-4,617

-4,495

-4,034

-3,799

-3,880

-3,859

-2,996

-5,127

-1,975

-1,925

Income tax expense

-

-

-

-

-

-

-

-

-

-

2

2

-

0

0

0

1

0

0

0

0

-

-

0

-

0

0

Net loss and comprehensive loss

-8,341

-5,713

-5,691

-7,816

-5,916

-6,014

-6,047

-6,153

-6,356

-5,666

-5,821

-5,693

-4,432

-4,186

-4,743

-4,594

-4,875

-4,617

-4,496

-4,035

-3,800

-3,881

-3,859

-2,996

-5,127

-1,975

-1,925

Deemed dividend related to warrants down round provision

2

21

0

0

99

-

636

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common shareholders

-8,344

-5,735

-5,691

-7,816

-6,016

-6,014

-6,684

-6,153

-6,356

-

-5,821

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average shares outstanding used in computing net loss per share attributable to common shareholders:
Basic

78,999

29,128

23,018

20,466

9,792

4,209

2,767

2,280

1,911

-19,190

986

901

20,969

15,673

8,370

7,702

6,566

-12,562

6,242

17,998

10,372

4,474

4,449

4,449

2,617

182

180

Diluted

78,999

29,128

23,018

20,466

9,792

4,209

2,759

2,280

1,911

-19,190

986

901

20,969

15,673

8,370

7,702

6,566

-12,562

6,242

17,998

10,372

4,474

4,449

4,449

2,617

182

180

Net loss per common share:
Basic

-0.11

-0.20

-0.25

-0.38

-0.61

-1.43

-2.42

-2.70

-3.33

-11.15

-5.90

-6.32

-0.21

-0.01

-0.57

-0.60

-0.74

-1.76

-0.72

-0.22

-0.37

-0.47

-0.87

-0.67

-1.96

-10.83

-10.67

Diluted

-0.11

-0.20

-0.25

-0.38

-0.61

-1.43

-2.42

-2.70

-3.33

-11.15

-5.90

-6.32

-0.21

-0.01

-0.57

-0.60

-0.74

-1.76

-0.72

-0.22

-0.37

-0.47

-0.87

-0.67

-1.96

-10.83

-10.67